Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 12, Issue 11
|
pp. 10162–10179
First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds
Back to article
Figure 4
(4 of 15)
−
100%
+
Figure 4.
Mitochondrial inhibitors: Mitoriboscins and bis-1,4-butene-TPP.
The chemical structures of the three Mitoriboscins (23/G4, 24/D4 and 24/F9) and Bis-TPP are shown.